![](/img/cover-not-exists.png)
PCN72 ECONOMIC EVALUATION OF SUNITINIB VS. INTERFERON-A AND BEVACIZUMAB + INTERFERON-A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (CCRM) – BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE
V Teich, CM Hashizume, T Marinho, C Charbonneau, A NavesVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72161-6
File:
PDF, 68 KB
english, 2010